ArticleOncotarget2017

SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.

Stefania Madonna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.